TIDMGWP
RNS Number : 3356P
GW Pharmaceuticals PLC
17 February 2016
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 18 AUGUST 2015 TO: 17 FEBRUARY 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
46,900 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
4,500 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
42,400 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
200,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
200,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
122,613 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
262,625,686 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 18 AUGUST 2015 TO: 17 FEBRUARY 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
56,978 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
653,799 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
144,737 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
500,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
800,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JANUARY 2015
500,000 ORDINARY SHARES OF 0.1P EACH ON 5 JUNE 2015
741,558 ORDINARY SHARES OF 0.1P EACH ON 8 SEPTEMBER 2015
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
262,625,686 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME
3. PERIOD OF RETURN:
FROM: 18 AUGUST 2015 TO: 17 FEBRUARY 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
205,750 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
5,500 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
200,250 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003
300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008
400,000 ORDINARY SHARES OF 0.1P EACH ON 18 JANUARY 2010
400,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
300,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
168,650 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
262,625,686 ORDINARY SHARES OF 0.1P EACH
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS LONG TERM INCENTIVE PLAN 2008
3. PERIOD OF RETURN:
FROM: 18 AUGUST 2015 TO: 17 FEBRUARY 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
763,043 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
874,414 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
647,071 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
600,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
300,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
1,000,000 ORDINARY SHARES OF 0.1P EACH ON 5 JUNE 2015
758,442 ORDINARY SHARES OF 0.1P EACH ON 8 SEPTEMBER 2015
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
262,625,686 ORDINARY SHARES OF 0.1P EACH
For further information, please contact:
Adam George, Company Secretary, GW Pharmaceuticals plc
Telephone: +44 (0)1223 266800
James Steel/Oliver Jackson, Nominated Adviser, Peel Hunt LLP
Telephone: +44 (0)20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRBDLFFQLFXBBQ
(END) Dow Jones Newswires
February 17, 2016 05:37 ET (10:37 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
